These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10679753)
1. Analysis of recent trends in prostate cancer incidence and mortality. Dennis LK; Resnick MI Prostate; 2000 Mar; 42(4):247-52. PubMed ID: 10679753 [TBL] [Abstract][Full Text] [Related]
2. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Brawley OW Cancer; 1997 Nov; 80(9):1857-63. PubMed ID: 9351560 [TBL] [Abstract][Full Text] [Related]
3. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964 [TBL] [Abstract][Full Text] [Related]
4. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts. Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398 [TBL] [Abstract][Full Text] [Related]
5. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Negoita S; Feuer EJ; Mariotto A; Cronin KA; Petkov VI; Hussey SK; Benard V; Henley SJ; Anderson RN; Fedewa S; Sherman RL; Kohler BA; Dearmon BJ; Lake AJ; Ma J; Richardson LC; Jemal A; Penberthy L Cancer; 2018 Jul; 124(13):2801-2814. PubMed ID: 29786851 [TBL] [Abstract][Full Text] [Related]
6. Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012. Hoffman RM; Meisner AL; Arap W; Barry M; Shah SK; Zeliadt SB; Wiggins CL Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):259-63. PubMed ID: 26646364 [TBL] [Abstract][Full Text] [Related]
7. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions? Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H; BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546 [TBL] [Abstract][Full Text] [Related]
8. Changes in prostate cancer incidence and treatment in USA. Lu-Yao GL; Greenberg ER Lancet; 1994 Jan; 343(8892):251-4. PubMed ID: 7905093 [TBL] [Abstract][Full Text] [Related]
9. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014. Li J; Siegel DA; King JB Ann Epidemiol; 2018 May; 28(5):328-330. PubMed ID: 29678312 [TBL] [Abstract][Full Text] [Related]
10. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Cetin K; Beebe-Dimmer JL; Fryzek JP; Markus R; Carducci MA Urology; 2010 Jun; 75(6):1396-404. PubMed ID: 19969335 [TBL] [Abstract][Full Text] [Related]
12. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Gilliland F; Becker TM; Smith A; Key CR; Samet JM Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631 [TBL] [Abstract][Full Text] [Related]
13. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program. Smart CR Cancer; 1997 Nov; 80(9):1835-44. PubMed ID: 9351557 [TBL] [Abstract][Full Text] [Related]
14. Evidence of prostate cancer "reverse stage migration" toward more advanced disease at diagnosis: Data from the Pennsylvania Cancer Registry. Reese AC; Wessel SR; Fisher SG; Mydlo JH Urol Oncol; 2016 Aug; 34(8):335.e21-8. PubMed ID: 27108226 [TBL] [Abstract][Full Text] [Related]
15. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates. Feuer EJ; Mariotto A; Merrill R Cancer; 2002 Aug; 95(4):870-80. PubMed ID: 12209732 [TBL] [Abstract][Full Text] [Related]
16. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score. Herget KA; Patel DP; Hanson HA; Sweeney C; Lowrance WT Cancer Med; 2016 Jan; 5(1):136-41. PubMed ID: 26628287 [TBL] [Abstract][Full Text] [Related]
17. Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Hebert JR; Ghumare SS; Gupta PC Asian Pac J Cancer Prev; 2006; 7(4):547-55. PubMed ID: 17250425 [TBL] [Abstract][Full Text] [Related]
18. Recent trends in prostate cancer in Canada. LeBlanc AG; Demers A; Shaw A Health Rep; 2019 Apr; 30(4):12-17. PubMed ID: 30994922 [TBL] [Abstract][Full Text] [Related]
19. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. Feuer EJ; Merrill RM; Hankey BF J Natl Cancer Inst; 1999 Jun; 91(12):1025-32. PubMed ID: 10379965 [TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity - United States, 2001-2017. Siegel DA; O'Neil ME; Richards TB; Dowling NF; Weir HK MMWR Morb Mortal Wkly Rep; 2020 Oct; 69(41):1473-1480. PubMed ID: 33056955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]